Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IRIDEX CORP Director's Dealing 2014

Apr 24, 2014

34978_dirs_2014-04-23_20b7de2c-deef-4380-abfc-0432441ef654.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRIDEX CORP (IRIX)
CIK: 0001006045
Period of Report: 2014-04-21

Reporting Person: Mackaness James H (CFO and COO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-04-21 Common Stock M 1000 $.90 Acquired 3000 Direct
2014-04-21 Common Stock S 1000 $8.646 Disposed 2000 Direct
2014-04-21 Common Stock M 2000 $.90 Acquired 4000 Direct
2014-04-21 Common Stock S 2000 $8.655 Disposed 2000 Direct
2014-04-22 Common Stock M 1000 $.90 Acquired 3000 Direct
2014-04-22 Common Stock S 1000 $9.00 Disposed 2000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-04-21 Stock Option Right to Buy $.90 M 4000 Disposed 2015-12-11 Common Stock (4000) Direct

Footnotes

F1: The sale reported in this Form 4 was pursuant to the Reporting Person's Rule 10b5-1 Selling Plan effective November 21, 2013.

F2: This option was granted pursuant to IRIDEX Corporation's 2008 Equity Incentive Plan and is exempt to Rule 16b-3.

F3: The shares are subject to vesting according to the following schedule: 1/48th of the total number of shares vest each month.